Wed, May 20, 2020
Tue, May 19, 2020
Mon, May 18, 2020

Robert Driscoll Upgraded (ABUS) to Buy and Increased Target to $4 on, May 19th, 2020

Robert Driscoll of Wedbush, Upgraded "Arbutus Biopharma Corporation" (ABUS) to Buy and Increased Target from $2 to $4 on, May 19th, 2020.

Robert has made no other calls on ABUS in the last 4 months.



There are 3 other peers that have a rating on ABUS. Out of the 3 peers that are also analyzing ABUS, 0 agree with Robert's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Robert


  • Madhu Kumar of "Baird" Maintained at Buy with Decreased Target to $4 on, Friday, March 27th, 2020
  • Keay Nakae of "Chardan Capital" Upgraded from Hold to Strong Buy and Increased Target to $5 on, Friday, March 6th, 2020
  • Liisa Bayko of "JMP Securities" Upgraded from Hold to Buy and Held Target at $10 on, Wednesday, February 5th, 2020